Target intelligence / Profile preview

DNA damage response and reactive oxygen species-related pathways (DDR/ROS pathways)

Target
DDR/ROS pathways
Molecular classification
Other, Signaling pathway
01

Overview

The DNA damage response (DDR) and reactive oxygen species (ROS)-related pathways constitute a sophisticated cellular network designed to preserve genomic stability and manage oxidative stress (Jackson & Bartek, 2009, Nature). The DDR identifies and repairs DNA lesions—such as single-strand and double-strand breaks—through coordinated signaling involving sensors like ATM and ATR and effectors like PARP (Lord & Ashworth, 2017, Science). Simultaneously, ROS-related pathways regulate the levels of reactive oxygen species, which are natural byproducts of metabolism that can cause significant oxidative damage to DNA, proteins, and lipids if not neutralized by antioxidant systems (Srinivas et al., 2019, Free Radic Biol Med). In oncology, these pathways are frequently exploited; for instance, PARP inhibitors are used to induce synthetic lethality in tumors with existing DNA repair defects, such as those with BRCA mutations (O'Connor, 2015, Mol Cell). Furthermore, modulating ROS levels can sensitize cancer cells to therapy or directly trigger programmed cell death, making these pathways critical focal points for therapeutic intervention and drug development (Gorrini et al., 2013, Nat Rev Drug Discov).

Other names
DDR pathwaysROS signalingOxidative stress responseDNA repair pathwaysRedox homeostasis signaling
02

Mechanism of action

Inhibition of DNA repair enzymes (e.g., PARP, ATR, ATM) to induce synthetic lethality in repair-deficient cells; modulation of cellular redox state to induce oxidative stress-mediated apoptosis; potentiation of DNA-damaging chemotherapy or radiotherapy.

03

Biological functions

DNA repairCell cycleApoptosisSignal transductionOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInfectionOther
05

Safety considerations

Hematologic toxicity (anemia, neutropenia, thrombocytopenia)Risk of secondary malignancies (e.g., Myelodysplastic syndrome/Acute myeloid leukemia)Gastrointestinal toxicityPotential for systemic oxidative damage to healthy tissues
06

Interacting drugs

Olaparib

6 more in the full profile.

07

Biomarkers

BRCA1 mutationBRCA2 mutationγH2AX (gamma-H2AX)8-oxoguanine (8-oxoG)Homologous recombination deficiency (HRD) scoreATM deficiency

Beyond the preview

Go deeper on DNA damage response and reactive oxygen species-related pathways (DDR/ROS pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA damage response and reactive oxygen species-related pathways (DDR/ROS pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call